'Exceptionalism,' Preemption And A Test For FDA Authority
The U.S. Food and Drug Administration's broad authority over drug approvals is being tested as state lawmakers impose new restrictions on mifepristone, the abortion drug that has seen surging use across...To view the full article, register now.
Already a subscriber? Click here to view full article